The global appetite stimulant market size was estimated at USD 1.73 billion in 2025 and is projected to reach USD 2.90 billion by 2033, growing at a CAGR of 6.76% from 2026 to 2033. The market addresses unmet needs in patients experiencing reduced appetite and unintended weight loss. ... Read More »
April 2026The U.S. vaccines market size was estimated at USD 26.00 billion in 2025 and is projected to reach USD 40.19 billion by 2033, growing at a CAGR of 5.40% from 2026 to 2033. The U.S. vaccines market is driven by rapid advancements in vaccine technologies and platform innovation.... Read More »
April 2026The global estrogen replacement therapy market size was estimated at USD 11.75 billion in 2025 and is projected to reach USD 18.36 billion by 2033, growing at a CAGR of 5.80% from 2026 to 2033. The market is primarily driven by the rising global population of menopausal and postmenopausa... Read More »
April 2026The global selective serotonin reuptake inhibitors market size was valued at USD 19.51 billion in 2025 and is projected to reach USD 30.25 billion by 2033, growing at a CAGR of 5.70% from 2026 to 2033. The industry is driven by the rising global prevalence of depression and anxiety disor... Read More »
April 2026The global osteoarthritis injectable market size was valued at USD 8.18 billion in 2025 and is projected to reach USD 14.16 billion by 2033, growing at a CAGR of 7.17% from 2026 to 2033. This growth is primarily driven by the increasing prevalence of osteoarthritis (OA), particularly amo... Read More »
April 2026The global preclinical CRO market size was estimated at USD 6.7 billion in 2025 and is projected to reach USD 12.8 billion by 2033, growing at a CAGR of 8.4% from 2026 to 2033. The market growth is driven by economic outsourcing, regulatory mandates, and scientific complexities, which, i... Read More »
April 2026The global complementary and alternative medicine for anti-aging & longevity market size was estimated at USD 99.56 billion in 2025 and is projected to reach USD 397.22 billion by 2033, growing at a CAGR of 18.34% from 2026 to 2033. The market is witnessing strong growth as individua... Read More »
April 2026The global neuropathic pain market size was estimated at USD 8.53 billion in 2025 and is projected to reach USD 15.23 billion by 2033, growing at a CAGR of 7.58% from 2026 to 2033. The neuropathic pain market was primarily driven by the rising global burden of chronic diseases, particula... Read More »
April 2026The Japan paroxysmal nocturnal hemoglobinuria treatment market was valued at USD 279.95 million in 2025 and is projected to reach USD 455.53 million by 2033, growing at a CAGR of 5.88% from 2026 to 2033. This growth is driven by continuous advancements in complement inhibitor therapies, ... Read More »
April 2026The global actinic keratosis treatment market size was estimated at USD 7.02 billion in 2025 and is projected to reach USD 10.13 billion by 2033, growing at a CAGR of 4.86% from 2026 to 2033. This growth is driven by the increasing prevalence of actinic keratosis due to prolonged ultravi... Read More »
April 2026The New York legal cannabis market size was estimated at USD 2.52 billion in 2025 and is expected to reach USD 6.06 billion by 2033, growing at a CAGR of 11.5% from 2026 to 2033. The market growth is driven by the legalization of cannabis, increasing awareness regarding the therape... Read More »
April 2026The South Africa traditional & complementary medicine market size was estimated at USD 1.40 billion in 2025 and is projected to reach USD 2.13 billion by 2033, growing at a CAGR of 5.6% from 2026 to 2033. The market represents a mature, system-driven healthcare segment characterized ... Read More »
March 2026The global cold plasma market size was estimated at USD 167.8 million in 2025 and is projected to reach USD 495.9 million by 2033, growing at a CAGR of 14.6% from 2026 to 2033. This growth is attributed to the overall development of the healthcare industry, which has increased the demand... Read More »
March 2026The global hereditary angioedema therapeutics market size was estimated at USD 3.60 billion in 2025 and is projected to reach USD 8.18 billion by 2033, growing at a CAGR of 10.43% from 2026 to 2033. The global hereditary angioedema therapeutics market is expanding due to increasing diagn... Read More »
March 2026The global medical foods market size was estimated at USD 26.1 billion in 2025 and is projected to reach USD 38.9 billion by 2033, growing at a CAGR of 6.0% from 2026 to 2033. The market growth is driven by the rising prevalence of chronic diseases like Alzheimer's, ADHD, osteoporosis, o... Read More »
March 2026The global pharmaceutical contract manufacturing market size was estimated at USD 141.74 billion in 2025 and is projected to reach USD 310.97 billion by 2033, growing at a CAGR of 10.45% from 2026 to 2033. The demand for contract manufacturing is gaining momentum due to ... Read More »
March 2026The global pharmaceutical manufacturing market size was estimated at USD 616.15 billion in 2025 and is projected to reach USD 990.55 billion by 2033, growing at a CAGR of 5.88% from 2026 to 2033. The market is driven by demand for advanced therapeutics, biologics, and high-volume generic... Read More »
March 2026The global parenteral nutrition market size was estimated at USD 7.97 billion in 2025 and is projected to reach USD 12.59 billion by 2033, growing at a CAGR of 5.87% from 2026 to 2033. This growth is attributed to the rising prevalence of gastrointestinal disorders, increasing premature births, and the growing incid... Read More »
March 2026The global hypertrophic cardiomyopathy therapeutics market size was estimated at USD 1.43 billion in 2025 and is projected to reach USD 2.16 billion by 2033, growing at a CAGR of 5.5% from 2026 to 2033. The industry is expanding due to the increasing adoption of targeted pharmacological ... Read More »
March 2026The global GLP-1 receptor agonist market size was estimated at USD 66.38 billion in 2025 and is projected to reach USD 185.32 billion by 2033, growing at a CAGR of 12.4% from 2026 to 2033. GLP-1 receptor agonists have become an important therapeutic class for managing type 2 diabetes and... Read More »
March 2026